Clinical Trial Update: Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating prednisone plus chloroquine for hyper-reactive malarial splenomegaly has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hyper-reactive Malarial Splenomegaly
• Malaria

Drugs mentioned

• Chloroquine (chloroquine)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Lihir Medical Centre | Conditions: Hyper-reactive Malarial Splenomegaly, Malaria | Phase 3 | Status: WITHDRAWN